Jurriën Prins

630 total citations
11 papers, 268 citations indexed

About

Jurriën Prins is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Jurriën Prins has authored 11 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Nephrology. Recurrent topics in Jurriën Prins's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Jurriën Prins is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Jurriën Prins collaborates with scholars based in Netherlands, Germany and United States. Jurriën Prins's co-authors include Anton Jan van Zonneveld, Ton J. Rabelink, Hetty C. de Boer, Jacques M.G.J. Duijs, Coen van Solingen, Menno V. Huisman, Eric P. van der Veer, Femke Groeneweg, Martin E. van Royen and Adriaan B. Houtsmuller and has published in prestigious journals such as PLoS ONE, Scientific Reports and European Heart Journal.

In The Last Decade

Jurriën Prins

10 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurriën Prins Netherlands 6 186 127 27 25 22 11 268
Valerio Azzimato Sweden 5 197 1.1× 93 0.7× 81 3.0× 18 0.7× 5 0.2× 5 270
Anna Cmoch Poland 6 97 0.5× 28 0.2× 24 0.9× 13 0.5× 12 0.5× 7 193
Rana Chakrabarti Canada 5 146 0.8× 39 0.3× 17 0.6× 41 1.6× 16 0.7× 7 227
Hemin Jiang China 10 166 0.9× 88 0.7× 21 0.8× 69 2.8× 38 1.7× 25 280
Petros Avramopoulos Germany 3 159 0.9× 107 0.8× 94 3.5× 20 0.8× 3 0.1× 3 230
Qun Shan China 7 214 1.2× 156 1.2× 8 0.3× 18 0.7× 9 0.4× 8 275
Ming Xia China 10 167 0.9× 90 0.7× 6 0.2× 19 0.8× 8 0.4× 28 292
Felipe Slebe Spain 7 98 0.5× 45 0.4× 7 0.3× 31 1.2× 9 0.4× 8 204
Nassim E. Ajami United States 5 217 1.2× 116 0.9× 38 1.4× 27 1.1× 5 0.2× 5 319
Laura Roca-Alonso United Kingdom 7 299 1.6× 259 2.0× 73 2.7× 12 0.5× 6 0.3× 8 406

Countries citing papers authored by Jurriën Prins

Since Specialization
Citations

This map shows the geographic impact of Jurriën Prins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurriën Prins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurriën Prins more than expected).

Fields of papers citing papers by Jurriën Prins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurriën Prins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurriën Prins. The network helps show where Jurriën Prins may publish in the future.

Co-authorship network of co-authors of Jurriën Prins

This figure shows the co-authorship network connecting the top 25 collaborators of Jurriën Prins. A scholar is included among the top collaborators of Jurriën Prins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurriën Prins. Jurriën Prins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Prins, Jurriën, Annabelle Biscans, Anton Jan van Zonneveld, Kendall S. Frazier, & Eric P. van der Veer. (2025). RNA-based therapeutic opportunities for the treatment of kidney diseases. Nature Reviews Nephrology. 22(1). 12–29.
2.
Essen, Mieke F. van, Nicole Schlagwein, Daniëlle J. van Gijlswijk‐Janssen, et al.. (2023). Preferential production and secretion of the complement regulator factor H-like protein 1 (FHL-1) by human myeloid cells. Immunobiology. 228(3). 152364–152364. 2 indexed citations
3.
Duijs, Jacques M.G.J., Maartje Klaver, Eline N. Kuipers, et al.. (2021). Estradiol-driven metabolism in transwomen associates with reduced circulating extracellular vesicle microRNA-224/452. European Journal of Endocrinology. 185(4). 539–552. 5 indexed citations
5.
Bruin, Ruben G. de, Gillian Vogel, Jurriën Prins, et al.. (2020). Targeting the RNA-Binding Protein QKI in Myeloid Cells Ameliorates Macrophage-Induced Renal Interstitial Fibrosis. Epigenomes. 4(1). 2–2. 7 indexed citations
6.
Solingen, Coen van, Elizabeth J. Hennessy, Mireille Ouimet, et al.. (2019). The Long Non-Coding Rna Chromr Regulates Cholesterol Homeostasis In Primates. Atherosclerosis. 287. e287–e287. 1 indexed citations
7.
Prins, Jurriën, Mieke F. van Essen, Jurjen M. Ruben, et al.. (2017). Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia–reperfusion injury in the rat. Nephrology Dialysis Transplantation. 33(1). 44–53. 33 indexed citations
8.
Bruin, Ruben G. de, Eric P. van der Veer, Jurriën Prins, et al.. (2016). The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression. Scientific Reports. 6(1). 21643–21643. 36 indexed citations
9.
Groeneweg, Femke, Martin E. van Royen, Susanne F. Fenz, et al.. (2014). Quantitation of Glucocorticoid Receptor DNA-Binding Dynamics by Single-Molecule Microscopy and FRAP. PLoS ONE. 9(3). e90532–e90532. 48 indexed citations
10.
Boer, Hetty C. de, Coen van Solingen, Jurriën Prins, et al.. (2013). Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. European Heart Journal. 34(44). 3451–3457. 131 indexed citations
11.
Boer, Hetty C. de, Coen van Solingen, Jurriën Prins, et al.. (2013). Abstract 487: Aspirin Treatment Hampers the Use of Plasma MicroRNA-126 as Biomarker for the Progression of Vascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 33(suppl_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026